Major Shareholding Notification • Feb 11, 2025
Major Shareholding Notification
Open in ViewerOpens in native device viewer

IBA (Ion Beam Applications), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on February 6, 2025.
IBA SA and IBA Investments SRL fell below the 3% threshold on 23/03/2024.
| Nom | Adresse (pour entités juridiques) |
|---|---|
| lon Beam Applications SA | Chemin du Cyclotron 3, 1348 Ottignies-Louvain-la-Neuve |
| IBA Investments SRL | Chemin du Cyclotron 3, 1348 Ottignies-Louvain-la-Neuve |



| A) Droits de vote | Notification précédente | Après la transaction | |||
|---|---|---|---|---|---|
| # droits de vote | # droits de vote | % de droits de vote | |||
| Détenteurs de droits de vote | Attachés à des titres Non liés à des titres | Attachés à des titres |
Non liés à des titres | ||
| lon Beam Applications SA | 1,124,617 | 1,019,252 | 2.51% | ||
| IBA Investments SRL | 51,973 | 103,946 | 0.26% | ||
| Sous-total | 1,176,590 | 1,123,198 | 2.77% | ||
| TOTAL | 1,123,198 | 0 | 2.77% | 0.00% |
| B) Instruments financiers assimilés |
Après la transaction | |||||||
|---|---|---|---|---|---|---|---|---|
| Détenteurs d'instruments financiers assimilés |
Type d'instrument financier | Date d'échéance DD/MM/YYYY |
Date ou délai d'exercice ou de conversion DD/MM/YYYY ou Texte |
# droits de vote pouvant être acquis en cas d'exercice de l'instrument |
% de droits de vote | Reglement | ||
| TOTAL | 0 | 0.00% | ||||||
| Les totaux ne seront mis à jour qu'après avoir utilisé la touche |
||||||||
| TOTAL (A & B) | # de droits de vote |
% de droits de vote | ||||||
| CALCULER | 1,123,198 | 2.77% |
IBA Investments SRL is the subsidiary of Ion Beam Applications SA, which is 100% owned by the latter.
IBA SA is not a controlled entity.
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2.000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at: www.iba-worldwide.com
Press release | 11//02/ 2025

IBA | Ion Beam Applications SA Chemin du Cyclotron, 3 | 1348 Louvain-la-Neuve | Belgium | RPM Brabant-wallon VAT : 0428.750.985 | T +32 10 47 58 11 | F +32 10 47 58 10 [email protected] | iba-worldwide.com


For further information, please contact:
Valérie Van Impe Paralegal +32479267809 [email protected]
Press release | 11//02/ 2025

IBA | Ion Beam Applications SA Chemin du Cyclotron, 3 | 1348 Louvain-la-Neuve | Belgium | RPM Brabant-wallon VAT : 0428.750.985 | T +32 10 47 58 11 | F +32 10 47 58 10 [email protected] | iba-worldwide.com

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.